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ABSTRACT
Background: Radiosurgery is defined as the use of high-dose ionizing radiation for precise and total destruction of a
chosen target, avoiding concomitant or delayed harm to adjacent tissues. The three types of radiations include gamma
rays (GammaKnife) by Cobalt-60, X8 rays using linear accelerator (LINAC) system, and charged-particles generated
from synchocyclotron. Recommendations: Based on current evidence, radiosurgery has proven benefits as the treatment of certain brain metastases, vestibular schwannomas, meningiomas, and some skull base tumors. Conclusion:
This review describes the current recommendations for use of radiosurgery for intracranial pathologies. Radiosurgery is
a relatively newer modality in the developing country of Pakistan. Much work is needed to increase awareness and
promote its use as and when indicated.
Keywords: Radiosurgery, Current recommendations, Pakistan
INTRODUCTION

further for improved dose planning and dose distribution
(3, 4)
. Moreover, since it does not involve a fixed frame
system, its use is extended to lesions outside the cranial
cavity (4). Charged-particle radiosurgery involve proton
beams generated using synchrocyclotrons. Only few of
these systems are available in United States, lacking
popularity mostly because of its high installation and
maintenance costs (4). The objective of this article is to
discuss the current recommendations for use of radiosurgeryin intracranial pathologies. We reviewed the latest
literature to define the indications and relative indications
for radiosurgery, and identify the cases where radiosurgery is not recommended. This article is also the first
attempt to highlight the current practices of radiosurgery
in the developing country, Pakistan. We interviewed the
providers of stereotactic radiosurgery in Pakistan, as well
as a few physicians at a tertiary care center in Pakistan,
whofollow the patients before or after radiosurgical treatment for their intracranial diseases.

The term “radiosurgery” was coined by Prof. Lars Leksell
from Karolinska Institute in Stockholm, Sweden. He
defined radiosurgery as the use of a high-dose ionizing
radiation for precise and total destruction of a chosen
target, avoiding concomitant or delayed harm to the
adjacent tissues (1). He also described the use of stereotactic methods to develop the principles of radiosurgery
in 1951 (2). Since its advent, radiosurgery has come a
long way to become an indication for treatment of a
number of intracranial pathologies. One of the types of
radiations involved in radiosurgery included the gamma
rays, and was termed Gamma Knife. Gamma knife
involves placement of a Leksell frame around the head of
the patient for stereotactic localization of the brain
lesion. This is followed by closed skull irradiation in a
single-treatment session. The frame is used to fix the
head of the patient, as multiple gamma ray beams focus
at the chosen target. Cobalt-60 is used as the generation
source (3). Gamma Knife has evolved to become one of
the indicated treatments for intracranial brain metastasis
and vascular malformations (4). Another type of ionizing
beam used for radiosurgery involved 1 the Linear Accelerator (LINAC) system to generate high-speed photons,
which subsequently produce X-rays focused at a desired
target lesion. The LINAC system avoids the use of fixed
frame; the patient lies in a steady position while the
LINAC head moves around to focus the target through
different arcs (4). The LINAC system has been developed

PAKISTAN JOURNAL OF NEUROLOGICAL SCIENCES

INDICATIONS
Brain Metastasis
Stereotactic radiosurgery (SRS) has shown survival rates
comparable to surgical resection followed by whole-brain
radiotherapy (5). SRS can be used for single or multiple
brain metastatic (6), for small lesions (less than 3-3.5cm)
(7)
, for surgically inaccessible lesions (5, 7), and for radioresistent tumors like melanoma and renal cell carcinoma (5, 6).
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Meningioma
SRS can be used a primary or adjuvant treatment for
meningiomas that arise within the base of skull and have
a high-surgical risk (8), SRS can also be used for recurrent skull base lesions (9). Better tumor control rates have
been observed for benign meningiomas (WHOGrade I –
about 95% at 5 years) as compared to atypical (WHO
Grade II – 60% at 5 years) ormalignant meningiomas
(WHO Grade III – 10% at 5 years) (10).

reotactic radiosurgery using cyber-knife may be used for
non-functioning large tumors, to prevent neuroendocrine
complications and visual pathway defects (26).
Gliomas
Even with significant risk of radiation complications (27,
28)
, the use of SRS is implicated in the treatment of
high-grade gliomas as a boost after external beam radiotherapy (EBRT), or for small focal recurrences (29).
However, the evidence is ambiguous and further
research isneeded in this area (27). For low-grade
gliomas, SRS may be used as an adjuvant to surgical
resection for residual or recurrent lesions, or for surgically inaccessible tumors (27, 30).

Vestibular 1 Schwannoma (Acoustic Neuromas)
SRS is indicated for solitary vestibular schwannomas
that are less than 30mm in cisternal diameter. Better
outcomes are reported in such patients (11). Treatment
success rates of 78.2% to 86.9% have been calculated
even after considering 17% to 30% natural growth rate
of tumors without intervention (12).

Craniopharyngioma
Stereotactic radiosurgery has a role as a primary treatment for small tumors (<3cm) (31), for recurrent
lesions (31-33), for patients who are not good candidates
for surgery (31), and for large tumors after surgical
decompression/ debulking or in the hypofractionated
form (33-35).

Nonvestibular Schwannoma (Nonacoustic Schwannoma)
Radiosurgery has shown good outcomes for trigeminal
(CN V), facial (CN VII) and jugular foramen (CN IX, X, XI)
schwannomas (13, 14); it can be used as a primary treatment for small to medium sized lesions, and as an
adjuvant for residual lesions after large tumor resections
(13-16)
.

Cavernous Hemangioma
SRS may be used to avoid operative complications of
excessive bleeding or damage to adjacent structures (36,
37)
. SRS may be a primary therapy for small to medium
sized lesions confirmed on typical imaging (36, 38), or
follow surgical resection for any residual tumor in cases
of large hemangiomas (36, 38).

GlomusJugulare
With good tumor control and lesser cranial nerve deficits
(IX, X, XI) as compared to gross total resection (17, 18),
stereotactic radiosurgery is indicated for elderly patients,
for patients with serious medical conditions, and for
residual or recurrent tumor (19-21).

Hemangioblastoma
With a reasonable outcome of treatment, SRS has a role
in management of small and solid hemangioblastomas
(39, 40)
, and those that cannot be resected surgically (39-42).
Chordoma
SRS is implicated in the management of chordomas with
reasonable local tumor control when used as an adjunct
to surgical resection, for residual and recurrent lesions
(43-46)
.

Arteriovenous Malformations (AVMs)
Stereotactic radiosurgery has shown complete occlusion
rates of 72-96% with small AVMs (up to 3ml) (22).
However, there is a notable risk of bleeding during the
latent period following radiosurgery and before obliteration of the lesion. Management of larger AVMs continues
to be challenging, and even though methods like Salvage
Therapy (ST), Staged Volume Radiosurgery (SVR) and
Hypofractionated Stereotactic Radiotherapy (HSRT) have
been used to avoid higher complication rates (22), multimodality treatment approach with embolization, microsurgery and/or radiosurgery is recommended (23).
RELATIVE INDICATIONS

Chondrosarcoma
Duration of less than 6 months between diagnosis and
radiosurgery, age greater than 40 years, and single or no
prior surgical resection are the factors that predict good
tumor control after stereotactic radiosurgery (19). Noting
that, SRS may have a role as an adjunct in select
patients after maximal surgical resection (19, 47, 48).

Pituitary Adenomas
Stereotactic radiosurgery may be used for small secreting pituitary adenomas that fail to respond to medical
management, and when surgery is contra-indicated (24).
However, theremay be a delay before remission and/or
side-effects of hypopituitarism (25). Hypofractionatedste-

Trigeminal Neuralgia
Gamma knife radiosurgery has shown poorer pain
control outcomes as compared to radiofrequency
ablation or microvascular decompression (49-52). However,
gamma knife radiosurgery avoids the operative complications (50-52), and 1 may be used for patients who
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cannot undergo invasive procedures (50). Other problems
associated with gamma knife radiosurgery include the
delayed affect on facial pain and complications of numbness and paresthesia, especially radiosurgery is
performed multiple times (49, 52).

remains controversial (66, 69).
Epilepsy
While stereotactic radiosurgery has shown benefits as a
treatment modality for epilepsy due to focal lesions
(tumors, arteriovenous malformations or cavernous
malformations) (70, 71), there is a lack of evidence to
adequately define its role in treatment of seizures
secondary to hypothalamic hamartomas or mesial
temporal lobe epilepsy; varying results of seizure control
and complications have been reported (70, 72-75). In
addition, there is a potential risk ofseizures in the initial
months after radiosurgery, due to a delay in the antiepileptic effect afterthis procedure (70, 71, 73, 74).

Movement Disorders (Essential Tremors,
Parkinson’s Disease, Multiple Sclerosis)
Gamma knife thalamotomy may improve tremors related
to Parkinson’s disease and essential tremors (53-56). The
problems associated with this treatment modality involve
the delay in the clinical effect and the complications of
sensory or motor impairments or speech difficulties that
may manifest months after the procedure (57-59).

Movement Disorders (Bradykinesia, dyskinesia,
rigidity)
Studies have shown varying improvement and complication outcomes after gamma knife pallidotomy for bradykinesia, dyskinesia and rigidity (57, 76-78). Further studies
are needed for definitive recommendations (57).

NOT RECOMMENDED
Brain metastases
Stereotactic radiosurgery is not recommended for
lesions greater than 3.5-4cm in diameter ofthose associated with obstruction of CSF and hydrocephalus (5).
Moreover, SRS should not be used for patients who
score less than 70 on KarnofskyPerformance Scale
(KPS) or have an uncontrolled systemic malignancy (5).

COMPLICATIONS
The complications of stereotactic radiosurgery could be
of acute or chronic type, and maypresent years after
the treatment. The risk of complications is dependant
on the dose and target volume administered. Brain
edema (79-81) and radiation-induced cerebral necrosis
(radio-necrosis) (27, 80-83) are well-known complications
of stereotactic radiosurgery, with a considerable risk of
injury to the structures nearby (e.g. optic chiasm, facial
nerve, etc.). Since there is a significant risk of such
morbid complications, careful planning and administration of stereotactic radiosurgery is of utmost importance in any center where it is practiced. Moreover,
vasculopathic complications such as aneurysm or varix
formation, stenotic or occlusive vasculopathy, and
development of secondary neoplasm have also
beenobservered (84, 85).

Arteriovenous Malformations (AVMs)
Radiosurgery after embolization of arteriovenous malformations has not been recommended in the past (60-62).
However, recent data suggest that embolization before
gamma knife radiosurgery may be used in some
selected cases of large AVMs (63).
Meningioma
For lesions presenting with increasing neurological
deficits, and for large superficial lesions, stereotactic
radiosurgery has shown poorer outcomes and should not
be used (8, 9).
Glioma
In case of newly diagnosed glioblastoma, SRS has no
survival benefit if administered before fractionated radiotherapy (27).

PRACTICES IN PAKISTAN
Gamma Knife Radiosurgery
Gamma Knife Radiosurgery first came to Pakistan in May
2008 at the Neurospinal and Medical Institute at Karachi. It was shortly followed by the first LINAC system
introduced at the same institute. Since its installation,
1700 cases of Gamma Knife, and 800 cases using the
LINAC system have been performed. Majority of the
procedures include Vestibular Schwannomas, Meningiomas, Pituitary Adenomas, Gliomas, and ArteriovenousMalformations. Other cases such as Craniopharyngiomas, tumors of Pineal region, and Cavernous malformations have also been treated. Patients are mostly from

Hemagioblastoma
SRS is not recommended for asymptomatic lesions (41),
or those with cystic component (64).
INCONCLUSIVE 1 EVIDENCE (CONTROVERSIAL)
Cavernous Malformation
While, some studies have shown good outcome and
regression of lesion after radiosurgery (65, 66), other
studies have highlighted obvious morbidity risks with only
limited benefits of this treatment modality (67, 68). Overall,
the use of radiosurgery for cavernous malformation
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and CyberKnife as one of the treatment options for
indicated lesions.
CONCLUSION

Sindh (including Karachi), followed by Punjab and
Khyber Pakhtunkhwa. With the apparent advantage of
shorter duration of treatment, and faster recovery,
Gamma Knife is becoming increasingly popular among
the patients. Nevertheless, its use must be limited to
treat the pathologies as and when indicated. There is
significant scope for further growth and development of
Gamma Knife radiosurgery in Pakistan. Additional
gamma knife systems, one in each province, would
make this treatment more accessible for patients, and
can improve the outcomes of diseases that are otherwise easily manageable in other parts of the world.

With the advancement in neuro-imaging, stereotactic
technology, and robotics, radiosurgery has become one
of the key modalities in treatment of various intracranial
pathologies. This review describes the current recommendations based on the most recent literature. With
the ongoing research to make tumor cells more radiosensitive and healthy cells more radioresistent,
additional applications of radiosurgery can be anticipated. Nevertheless,stereotactic radiosurgery is not free
from complications; it is very important to carefully
evaluate individual cases in a multi-disciplinary setting
before using stereotactic radiosurgeryas a treatment
modality, and administer the radiation in a strictly
controlled fashion.

LINAC (CyberKnife) Radiosurgery
LINAC (CyberKnife) system was introduced in Pakistan
even more recently than Gamma Knife. Patients’ Aid
Foundation, a non-governmental organization (NGO),
helped install theCyberKnife system at Jinnah
Postgraduate Medical Center (JPMC) in Karachi in
2011. Sinceits installation, 905 sessions have been
given to 269 patients from all over the country, and
abroad. The treatment is offered for various lesions in
the brain and the rest of the body. Majority of the
patients come from Sindh (including Karachi), followed
by the rest of the provinces.

Concurrently, as compared to the developed parts of the
world, radiosurgery is relatively a new concept in a developing country like Pakistan; there have been only less
than 6 years of experience in Gamma Knife, and 2 years
of experience in CyberKnife procedures. There is a dire
need to spread awareness and form a good referral
system, so patients can benefit from radiosurgery as and
when indicated. Moreover, additional equipment is
needed to make thistreatment more accessible for
patients and improve the outcomes of otherwise manageable diseases.

The intracranial pathologies for which CyberKnife has
been used include Vestibular Schwannomas, Meningioma, Brain metastases, Arteriovenous malformations,
Craniopharyngioma, Pituitary Adenoma, Trigeminal
Neuralgia, Giant cell tumor, Ependymoma, Glomus
tumors, and others. Extracranial lesions in the prostate,
lymph node, liver and spine are also treated with
CyberKnife Radiosurgery. Initial follow-up results have
shown good outcomes with the use of CyberKnife.
However, a longer follow-up would be required for
substantial conclusions. 9
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Room for improvement
Stereotactic radiosurgery in Pakistan is a fairly recent
treatment modality as compared to its introduction and
use in the developed parts of the world; there is a significant room for improvement in this field to provide better
healthcare for the patients. Stereotactic radiosurgery
requires a multi-disciplinary approach to evaluate the
patient’s disease, and manage it according to the best
possible evidence. Additional equipment with experienced operators is needed in various cities across the
country to make this treatment modality more accessible and improve the quality of care provided by the
involved healthcare personnel.

REFERENCES
1.

2.

Similarly, a good referral system will improve the followup of patients undergoing stereotactic radiosurgery,
providing a means to monitor and utilize Gamma Knife

PAKISTAN JOURNAL OF NEUROLOGICAL SCIENCES

3.

35

Larsson B, Leksell L, Rexed B, Sourander P, Mair W,
Andersson B. The high-energyproton beam as a
neurosurgical tool. Nature. 1958;182(4644):
1222-3.
Leksell L. The stereotaxic method and radiosurgery
of the brain. Actachirurgica. Scandinavica. 1951;
102(4):316-9.
Vesper J, Bolke B, Wille C, Gerber PA, Matuschek
C, Peiper M, et al. Currentconcepts in stereotactic

VOL. 9 (2) APR - JUN 2014

4.

5.
6.

7.
8.
9.

10.

11.

12.

13.
14.

15.

16.

radiosurgery - a neurosurgical and radiooncological
point of view.European journal of medical research.
2009;14(3):93-101.
Niranjan A, Maitz AH, Lunsford A, Gerszten PC,
Flickinger JC, Kondziolka D, et al.Radiosurgery
Techniques and Current Devices. In: Szeifert GT,
Kondziolka D, Levivier M, Lunsford LD, editors.
Radiosurgery and Pathological Fundamentals. 20:
Karger Publishers; 2007.
Young RF. Radiosurgery for the treatment of brain
metastases. Seminars in surgicaloncology. 1998;
14(1):70-8.
Lippitz B, Lindquist C, Paddick I, Peterson D, O'Neill
K, Beaney R. Stereotacticradiosurgery in the treat
ment of brain metastases: the current evidence.
Cancer treatmentreviews. 2014;40(1):48-59.
Soffietti R, Ruda R, Mutani R. Management of
brain metastases. Journal of neurology.2002;
249(10):1357-69.
Bloch O, Kaur G, Jian BJ, Parsa AT, Barani IJ.
Stereotactic radiosurgery for benignmeningiomas.
Journal of neuro-oncology. 2012;107(1):13-20.
Kreil W, Luggin J, Fuchs I, Weigl V, Eustacchio S,
Papaefthymiou G. Long termexperience of gamma
knife radiosurgery for benign skull base meningi
omas. Journal ofneurology, neurosurgery, and
psychiatry. 2005;76(10):1425-30.
Pollock BE, Stafford SL, Link MJ. Stereotactic
radiosurgery of intracranialmeningiomas. Neuro
surgery clinics of North America. 2013;24(4): 499507.
Wolbers JG, Dallenga AH, Mendez Romero A, van
Linge A. What intervention is bestpractice for
vestibular schwannomas? A systematic review of
controlled studies. BMJ open. 2013;3(2).
Miller T, Lau T, Vasan R, Danner C, Samy Youssef A,
van Loveren H, et al.Reporting success rates in the
treatment of vestibular schwannomas: Are we
accounting for the natural history? Journal of
clinical neuroscience : official journal of the Neuro
surgical Society of Australasia. 2014.
Hasegawa T. Stereotactic radiosurgery for nonves
tibularschwannomas. Neurosurgery clinics of North
America. 2013;24(4):531-42.
Pollock BE, Foote RL, Stafford SL. Stereotactic
radiosurgery: the preferred management for patients
with nonvestibularschwannomas? International
journal of radiation oncology, biology, physics. 2002;
52(4):1002-7.
Kimball MM, Foote KD, Bova FJ, Chi YY, Friedman
WA. Linear acceleratorradiosurgery for nonvestibu
larschwannomas. Neurosurgery. 2011;68(4):
974-84;
Safavi-Abbasi S, Bambakidis NC, Zabramski JM,

PAKISTAN JOURNAL OF NEUROLOGICAL SCIENCES

17.

18.

19.

20.

21.

22.

23.

24.

25.
26.

27.

36

Workman R, Verma K, Senoglu M,et al. Nonves
tibularschwannomas: an evaluation of functional
outcome after radiosurgicaland microsurgical
management. Actaneurochirurgica. 2010;152(1):
35-46.
Guss ZD, Batra S, Limb CJ, Li G, Sughrue ME,
Redmond K, et al. Radiosurgery ofglomusjugulare
tumors: a meta-analysis. International journal of
radiation oncology, biology, physics. 2011;81(4):
e497-502.
Ivan ME, Sughrue ME, Clark AJ, Kane AJ, Aranda D,
Barani IJ, et al. A metaanalysisof tumor control
rates and treatment-related morbidity for patients
with glomusjugulare tumors. Journal of neurosur
gery. 2011;114(5):1299-305.
Kano H, Lunsford LD. Stereotactic radiosurgery of
intracranial chordomas, chondrosarcomas, and
glomus tumors. Neurosurgery clinics of North
America. 2013;24(4):553-60.
Lieberson RE, Adler JR, Soltys SG, Choi C, Gibbs IC,
Chang SD. Stereotacticradiosurgery as the primary
treatment for new and recurrent paragangliomas: is
open surgical resection still the treatment of
choice? World neurosurgery. 2012;77(5-6):745-61.
Hafez RF, Morgan MS, Fahmy OM. The safety and
efficacy of gamma knife surgery in management of
glomusjugulare tumor. World journal of surgical
oncology. 2010;8:76.
Jones J, Jang S, Getch CC, Kepka AG, Marymont
MH. Advances in the radiosurgicaltreatment of
large inoperable arteriovenous malformations.
Neurosurgical focus.2007;23(6):E7.
Smith KA, Shetter A, Speiser B, Spetzler RF. Angio
graphic follow-up in 37 patientsafter radiosurgery
for cerebral arteriovenous malformations as part of
a multimodality treatment approach. Stereotactic
and functional neurosurgery. 1997;69(1-4 Pt 2):
136-42.
Kim W, Clelland C, Yang I, Pouratian N. Compre
hensive review of stereotacticradiosurgery for medi
cally and surgically refractory pituitary adenomas.
Surgical neurology international. 2012;3(Suppl 2):
S79-89.
Castinetti F, Brue T. Gamma Knife radiosurgery in
pituitary adenomas: Why, who,and how to treat?
Discovery medicine. 2010;10(51):107-11.
Iwata H, Sato K, Tatewaki K, Yokota N, Inoue M,
Baba Y, et al. Hypofractionatedstereotactic radio
therapy with CyberKnife for nonfunctioning pituitary
adenoma: high localcontrol with low toxicity. Neurooncology. 2011;13(8):916-22.
Tanaka S, Shin M, Mukasa A, Hanakita S, Saito K,
Koga T, et al. Stereotacticradiosurgery for intracra
nial gliomas. Neurosurgery clinics of North America.

VOL. 9 (2) APR - JUN 2014

28.

29.

30.

31.

32.

33.

34.

35.
36.

37.

38.

39.

2013;24(4):605-12.
Elaimy AL, Mackay AR, Lamoreaux WT, Demakas
JJ, Fairbanks RK, Cooke BS, etal. Clinical
outcomes of gamma knife radiosurgery in the
salvage treatment of patients with recurrent highgrade glioma. World neurosurgery. 2013;80(6):
872-8.
Sheehan J. Stereotactic radiosurgery for high-grade
gliomas: available evidence andthe need for further
investigation. World neurosurgery. 2013;80(6):
814-6.
Henderson MA, Fakiris AJ, Timmerman RD, Worth
RM, Lo SS, Witt TC. Gammaknife stereotactic
radiosurgery for low-grade astrocytomas. Stereo
tactic and functionalneurosurgery. 2009;87(3):
161-7.
Liubinas SV, Munshey AS, Kaye AH. Management
of recurrent craniopharyngioma.Journal of clinical
neuroscience : official journal of the Neurosurgical
Society of Australasia.2011;18(4):451-7.
Mortini P, Gagliardi F, Boari N, Losa M. Surgical
strategies and modern therapeuticoptions in the
treatment of craniopharyngiomas. Critical reviews
in oncology/hematology. 2013;88(3):514-29.
Niranjan A, Kano H, Mathieu D, Kondziolka D,
Flickinger JC, Lunsford LD.Radiosurgery for crani
opharyngioma. International journal of radiation
oncology, biology,physics. 2010;78(1):64-71.
Iwata H, Tatewaki K, Inoue M, Yokota N, Baba Y,
Nomura R, et al. Single andhypofractionated
stereotactic radiotherapy with CyberKnife for crani
opharyngioma. Journal of neuro-oncology. 2012;
106(3):571-7.
Veeravagu A, Lee M, Jiang B, Chang SD. The role of
radiosurgery in the treatment ofcraniopharyngio
mas. Neurosurgical focus. 2010;28(4):E11.
Wang X, Mei G, Liu X, Dai J, Pan L, Wang E. The role
of stereotactic radiosurgery incavernous sinus
hemangiomas: a systematic review and metaanalysis. Journal of neurooncology. 2012;107(2):
239-45.
Chou CW, Wu HM, Huang CI, Chung WY, Guo WY,
Shih YH, et al. Gamma knifesurgery for cavernous
hemangiomas in the cavernous sinus. Neurosur
gery. 2010;67(3):611-6;
Yin YH, Yu XG, Xu BN, Zhou DB, Bu B, Chen XL.
Surgical management of largeand giant cavernous
sinus hemangiomas. Journal of clinical neurosci
ence : official journal of the Neurosurgical Society
of Australasia. 2013;20(1):128-33.
Hanakita S, Koga T, Shin M, Takayanagi S, Mukasa
A, Tago M, et al. The long-termoutcomes of radio
surgery for intracranial hemangioblastomas.
Neuro-oncology. 2013.

PAKISTAN JOURNAL OF NEUROLOGICAL SCIENCES

40.

41.

42.

43.

44.

45.
46.

47.
48.

49.

50.

51.

52.
53.

37

Karabagli H, Genc A, Karabagli P, Abacioglu U,
Seker A, Kilic T. Outcomes ofgamma knife treat
ment for solid intracranial hemangioblastomas.
Journal of clinicalneuroscience : official journal of
the Neurosurgical Society of Australasia. 2010;
17(6):706Asthagiri AR, Mehta GU, Zach L, Li X, Butman JA,
Camphausen KA, et al.Prospective evaluation of
radiosurgery for hemangioblastomas in von HippelLindau disease. Neuro-oncology. 2010;12(1):80-6.
Kano H, Niranjan A, Mongia S, Kondziolka D,
Flickinger JC, Lunsford LD. The roleof stereotactic
radiosurgery for intracranial hemangioblastomas.
Neurosurgery.2008;63(3):443-50;discussion50-1.
Dassoulas K, Schlesinger D, Yen CP, Sheehan J.
The role of Gamma Knife surgery in the treatment
of skull base chordomas. Journal of neurooncology. 2009;94(2):243-8.
Liu AL, Wang ZC, Sun SB, Wang MH, Luo B, Liu P.
Gamma knife radiosurgery forresidual skull base
chordomas. Neurological research. 2008;30(6):
557-61.
Yamada Y, Gounder M, Laufer I. Multidisciplinary
management of recurrentchordomas. Current
treatment options in oncology. 2013;14(3):442-53.
Ouyang T, Zhang N, Zhang Y, Jiao J, Ren J, Huang T,
et al. Clinical Characters,Immunohistochemistry,
and Outcomes of 77 Patients with Skull Base Chor
domas. Worldneurosurgery. 2013.
Bloch O, Parsa AT. Skull base chondrosarcoma:
evidence-based treatment paradigms. Neurosur
gery clinics of North America. 2013;24(1):89-96.
Hasegawa T, Ishii D, Kida Y, Yoshimoto M, Koike J,
Iizuka H. Gamma Knife surgeryfor skull base
chordomas and chondrosarcomas. Journal of
neurosurgery. 2007;107(4):752-7.
Elaimy AL, Hanson PW, Lamoreaux WT, Mackay AR,
Demakas JJ, Fairbanks RK, etal. Clinical outcomes
of gamma knife radiosurgery in the treatment of
patients with trigeminal neuralgia. International
journal of otolaryngology. 2012;2012:919186.
Lee JK, Choi HJ, Ko HC, Choi SK, Lim YJ. Long term
outcomes of gamma kniferadiosurgery for typical
trigeminal neuralgia-minimum 5-year follow-up.
Journal of KoreanNeurosurgical Society. 2012;
51(5):276-80.
Linskey ME, Ratanatharathorn V, Penagaricano J. A
prospective cohort study ofmicrovascular decom
pression and Gamma Knife surgery in patients with
trigeminalneuralgia. Journal of neurosurgery. 2008;
109 Suppl:160-72.
Zakrzewska JM, Linskey ME. Trigeminal neuralgia.
Clinical evidence. 2009;2009.
Duma CM, Jacques DB, Kopyov OV, Mark RJ,

VOL. 9 (2) APR - JUN 2014

54.

55.

56.

57.

58.

59.

60.

61.

62.

63.

64.

65.

Copcutt B, Farokhi HK. Gamma kniferadiosurgery
for thalamotomy in parkinsonian tremor: a five-year
experience. Journal ofneurosurgery. 1998;88(6):
1044-9.
Kondziolka D, Ong JG, Lee JY, Moore RY, Flickinger
JC, Lunsford LD. GammaKnife thalamotomy for
essential tremor. Journal of neurosurgery. 2008;
108(1):111-7.
Mathieu D, Kondziolka D, Niranjan A, Flickinger J,
Lunsford LD. Gamma knifethalamotomy for multi
ple sclerosis tremor. Surgical neurology. 2007;
68(4):394-9.
Niranjan A, Kondziolka D, Baser S, Heyman R,
Lunsford LD. Functional outcomesafter gamma
knife thalamotomy for essential tremor and
MS-related tremor. Neurology.2000;55(3):443-6.
Elaimy AL, Arthurs BJ, Lamoreaux WT, Demakas JJ,
Mackay AR, Fairbanks RK, etal. Gamma knife
radiosurgery for movement disorders: a concise
review of the literature. World journal of surgical
oncology. 2010;8:61.
Lim SY, Hodaie M, Fallis M, Poon YY, Mazzella F,
Moro E. Gamma knifethalamotomy for disabling
tremor: a blinded evaluation. Archives of neurology.
2010;67(5):584-8.
Young RF, Li F, Vermeulen S, Meier R. Gamma Knife
thalamotomy for treatment ofessential tremor:
long-term results. Journal of neurosurgery. 2010;
112(6):1311-7.
Pollock BE, Flickinger JC, Lunsford LD, Maitz A,
Kondziolka D. Factors associatedWith successful
arteriovenous malformation radiosurgery. Neuro
surgery. 1998;42(6):1239-44;
Andrade-Souza YM, Ramani M, Scora D, Tsao MN,
terBrugge K, Schwartz ML.Embolization before
radiosurgery reduces the obliteration rate of
arteriovenousmalformations. Neurosurgery. 2007;
60(3):443-51; discussion 51-2.
Miyawaki L, Dowd C, Wara W, Goldsmith B, Albright
N, Gutin P, et al. Five yearresults of LINAC radiosur
gery for arteriovenous malformations: outcome for
large AVMS.International journal of radiation oncol
ogy, biology, physics. 1999;44(5):1089-106.
Izawa M, Chernov M, Hayashi M, Iseki H, Hori T,
Takakura K. Combinedmanagement of intracranial
arteriovenous malformations with embolization and
gamma knife radiosurgery: comparative evaluation
of the long-term results. Surgical neurology. 2009;
71(1):43-52; discussion -3.
Matsunaga S, Shuto T, Inomori S, Fujino H,
Yamamoto I. Gamma knife radiosurgeryfor intracra
nial haemangioblastomas. Actaneurochirurgica.
2007;149(10):1007-13;
Niranjan A, Lunsford LD. Stereotactic radiosurgery

PAKISTAN JOURNAL OF NEUROLOGICAL SCIENCES

66.
67.
68.

69.
70.
71.
72.
73.

74.

75.

76.

77.

78.

79.

38

guidelines for the management ofpatients with
intracranial cavernous malformations. Progress in
neurological surgery. 2013;27:166-75.
Liscak R. Radiosurgery of brain cavernomas--longterm results. Progress inneurological surgery.
2013;27:147-56.
Bertalanffy H, Gerganov VM. Microsurgical or radio
surgical management ofintracranial cavernomas.
Actaneurochirurgica Supplement.2013;116:103 -6.
Liscak R, Urgosik D, Simonova G, Vymazal J, Sem
nicka J. Gamma kniferadiosurgery of brain caverno
mas. Actaneurochirurgica Supplement. 2013;116:
107-11.
Nagy G, Kemeny AA. Stereotactic radiosurgery of
intracranial cavernousmalformations. Neurosurgery
clinics of North America. 2013;24(4):575-89.
Quigg M, Rolston J, Barbaro NM. Radiosurgery for
epilepsy: clinical experience andpotential antiepi
leptic mechanisms. Epilepsia. 2012;53(1):7-15.
Quigg M, Barbaro NM. Stereotactic radiosurgery for
treatment of epilepsy. Archivesof neurology. 2008;
65(2):177-83.
Yang I, Barbaro NM. Advances in the radiosurgical
treatment of epilepsy. Epilepsycurrents / American
Epilepsy Society. 2007;7(2):31-5.
Kawamura T, Onishi H, Kohda Y, Hirose G. Serious
adverse effects of gamma kniferadiosurgery for
mesial temporal lobe epilepsy. Neurologia medicochirurgica.2012;52(12):892-8.
Regis J, Rey M, Bartolomei F, Vladyka V, Liscak R,
Schrottner O, et al. Gamma knifesurgery in mesial
temporal lobe epilepsy: a prospective multicenter
study. Epilepsia.2004;45(5):504-15.
Quigg M, Broshek DK, Barbaro NM, Ward MM,
Laxer KD, Yan G, et al.Neuropsychological
outcomes after Gamma Knife radiosurgery for
mesial temporal lobeepilepsy: a prospective multi
center study. Epilepsia. 2011;52(5):909-16.
Duma CM, Jacques D, Kopyov OV. The treatment of
movement disorders usingGamma Knife stereotac
tic radiosurgery. Neurosurgery clinics of North
America.1999;10(2):379-89.
Friedman JH, Epstein M, Sanes JN, Lieberman P,
Cullen K, Lindquist C, et al.Gamma knife pallidotomy
in advanced Parkinson's disease. Annals of neurol
ogy. 1996;39(4):535-8.
Young RF, Vermeulen S, Posewitz A, ShumwayCook A. Pallidotomy with thegamma knife: a
positive experience. Stereotactic and functional
neurosurgery. 1998;70Suppl1:218-28.
Lee CC, Yen CP, Xu Z, Schlesinger D, Sheehan J.
Large intracranial metastatictumors treated by
Gamma Knife surgery: outcomes and prognostic
factors. Journal ofneurosurgery. 2014;120(1):52-9.

VOL. 9 (2) APR - JUN 2014

80.

81.

82.

Parkhutik V, Lago A, Aparici F, Vazquez JF, Tembl JI,
Guillen L, et al. Late clinicaland radiological compli
cations of stereotactical radiosurgery of arterio
venous malformations of the brain. Neuroradiology.
2013;55(4):405-12.
Samblas J, Luis Lopez Guerra J, Bustos J, Angel
Gutierrez-Diaz J, Wolski M, PerazaC, et al. Stereo
tactic radiosurgery in patients with multiple intrac
ranial meningiomas. Journal of BUON : official
journal of the Balkan Union of Oncology. 2014;
19(1):250-5.
Minniti G, Clarke E, Lanzetta G, Osti MF, Trasimeni
G, Bozzao A, et al. Stereotacticradiosurgery for
brain metastases: analysis of outcome and risk of
brain radionecrosis. Radiation oncology. 2011;

83.

84.

85.

6:48.
Telera S, Fabi A, Pace A, Vidiri A, Anelli V, Carapella
CM, et al. Radionecrosisinduced by stereotactic
radiosurgery of brain metastases: results of surgery
and outcome ofdisease. Journal of neuro-oncology.
2013;113(2):313-25.
Gross BA, Ropper AE, Du R. Vascular complications
of stereotactic radiosurgery forarteriovenous
malformations. Clinical neurology and neurosur
gery. 2013;115(6):713-7.
Patel TR, Chiang VL. Secondary Neoplasms After
Stereotactic Radiosurgery. Worldneurosurgery.
2014;81(3-4):594-9.

Conflict of Interest: Author declares no conflict of interest.
Funding Disclosure: Nil
Author’s Contribution:
Dr. Hussain Shallwani: Study concept and design, data collection, data analysis, manuscript writing, manuscript review
Sohaib Tariq: Data collection, data analysis, manuscript writing, manuscript review
Dr. Muhammad E Bari: Study concept and design, protocol writing, data collection, data
analysis, manuscript writing, manuscript review

PAKISTAN JOURNAL OF NEUROLOGICAL SCIENCES

39

VOL. 9 (2) APR - JUN 2014

